Innovation & IP

Future Inventions & Biotechnology Innovation

Genuine inventions, documented patent filings, and future research concepts from Alkhaleeli BioAI LLC — clearly distinguishing granted patents, provisional applications, and unfiled concepts.

Development stages are labeled explicitly: Granted Patent (issued U.S. patent), Provisional Filing (early-stage USPTO application — not an issued patent), In Development (internal documented program), and Concept — Unfiled(unfiled research concept). No concept is claimed as patented, tested, or commercially launched without documentation.

Biotechnology Inventions

Biotechnology Inventions

Provisional Filing

AI-Guided mRNA Research Systems

A research-only AI-guided workflow for identifying cancer-associated targets, prioritizing possible mRNA vaccine candidates, and using CRISPR-based concepts for antigen-validation research.

Research objective: Enable systematic, reproducible, AI-assisted design of personalized mRNA vaccine research candidates.

Potential application: Personalized oncology research programs and mRNA vaccine R&D pipelines.

USPTO Provisional Application 63/936,055

Provisional Filing

AI-Designed Synthetic Binding Protein Biosensor Platform

An AI-designed colorimetric biosensor platform using synthetic binding proteins for rapid detection and classification of Gram-negative bacteria, Gram-positive bacteria, and fungal pathogens.

Research objective: Provide fast, portable molecular detection and classification of microbial pathogens.

Potential application: Rapid diagnostic research and prototype development (not clinical diagnostic use unless validated and cleared).

USPTO Provisional Application 64/004,904

Provisional Filing

Lateral Flow IgE Immunoassay Apparatus

A rapid lateral-flow immunoassay concept for detecting and estimating allergen-specific IgE antibodies in a portable test format.

Research objective: Support fast, accessible allergy-related screening research.

Potential application: Point-of-need allergy screening research formats.

USPTO Provisional Application 63/931,575

In Development

Computational Drug-Development Platforms

AI frameworks for computational therapeutic design, drug-target evaluation, candidate prioritization, and biomedical decision-support systems.

Research objective: Accelerate early-stage drug discovery investigation with reproducible computational workflows.

Potential application: Pharmaceutical and biotech R&D teams evaluating therapeutic concepts.

Internal research program

In Development

RNA Therapeutic & Protein-Engineering Concepts

Concepts spanning mRNA construct assessment, sequence-optimization logic (including the Rami Five-Checkpoint Framework, R5CF), and engineered protein research designs.

Research objective: Systematize the design and evaluation of RNA-based therapeutic research concepts.

Potential application: mRNA vaccine and RNA therapeutic research blueprints.

Internal research program

Concept — Unfiled

Integrated Biomedical Engineering Systems

Integrated biomedical engineering concepts combining AI, computational modeling, and diagnostic platform design.

Research objective: Unify AI modeling and diagnostic platform engineering into coherent research systems.

Potential application: Future diagnostic and biomedical research platform development.

Internal research concept

Future Technology

Future Technology

Granted Patent

Implant-Support & Osseointegration Technology

A granted U.S. patent, "Method and Apparatus for Improving Osseointegration, Functional Load, and Overall Strength of Intraosseous Implants," covering implant-surface technology designed to improve osseointegration and biological integration. Rami M. Alkhaleeli, Founder and CEO of Alkhaleeli BioAI LLC, is a named co-inventor (with Vagan Tapaltsyan, Morshed Khandaker, Shahram Riahinezhad, and Niyaf Nidhal Kadhem Alkadhem). The patent is presented as part of the founder's professional innovation background and is not intellectual property owned or licensed by Alkhaleeli BioAI LLC; no institutional endorsement or commercial partnership with UCO is implied.

Research objective: Improve long-term implant stability and functional load distribution.

Potential application: Biomedical device design and functional support engineering.

US Patent No. 11,058,521 (granted July 13, 2021) — assigned to the University of Central Oklahoma

View public patent record
Provisional Filing

Magneto-Mechanical RF Energy Harvester

A five-stage energy-harvesting concept combining magneto-mechanical motion and RF energy capture for battery-free or emergency power applications.

Research objective: Enable micro-power generation without batteries for portable devices.

Potential application: Battery-free phone concepts and emergency power research.

USPTO Provisional Application 64/017,342

Concept — Unfiled

AI Computing Cooling Innovations

Early conceptual work on cooling approaches for high-density AI computing hardware.

Research objective: Explore thermal-management concepts for computational research infrastructure.

Potential application: Future AI computing platform research.

Internal research concept

In Development

Scientific Automation & Research Platforms

Software platforms for bioinformatics analysis, automated scientific report generation, sequence scoring, and research workflow automation.

Research objective: Automate and standardize computational research pipelines.

Potential application: Internal research tooling and client research workflows.

Internal research program

Concept — Unfiled

Biomedical Engineering Concepts

Future biomedical engineering concepts under early exploration, including novel device and diagnostic formats.

Research objective: Identify next-generation biomedical device and diagnostic research directions.

Potential application: Long-range biomedical R&D planning.

Internal research concept

Collaborate on Our Innovation Portfolio

Biotechnology companies, research organizations and investors interested in licensing, joint research, or co-development of these invention concepts are invited to get in touch.

Discuss R&D Collaboration
USPTO Filings

USPTO Patent Portfolio & Innovation Filings

Biotechnology • AI Diagnostics • mRNA Research • Biosensors • Energy Innovation

Rami M. Alkhaleeli's innovation portfolio includes one granted U.S. patent and multiple USPTO provisional patent applications across biomedical device design, AI-guided mRNA research, rapid immunoassay concepts, AI-designed biosensor platforms, and magneto-mechanical energy-harvesting technology.

Granted Patent

Method and Apparatus for Improving Osseointegration, Functional Load, and Overall Strength of Intraosseous Implants

US Patent No.11,058,521
GrantedJuly 13, 2021
Assignee / Co-InventorsUniversity of Central Oklahoma — Rami Mohanad Mahdi Alkhaleeli, Vagan Tapaltsyan, Morshed Khandaker, Shahram Riahinezhad, and Niyaf Nidhal Kadhem Alkadhem

Rami M. Alkhaleeli, Founder and CEO of Alkhaleeli BioAI LLC, is a named co-inventor of U.S. Patent No. 11,058,521, assigned to the University of Central Oklahoma. This patent relates to implant-surface technologies designed to improve osseointegration and biological integration. This patent is presented as part of the founder's professional innovation background. It is not represented as intellectual property owned or licensed by Alkhaleeli BioAI LLC. No institutional endorsement or commercial partnership with UCO is implied.

View public patent record
Provisional Filing

AI-guided personalized mRNA cancer vaccines with CRISPR-based antigen validation

Application No.63/936,055
Receipt DateOctober 30, 2025
InventorRami Mohaned Mahdi Alkhaleeli

This provisional filing describes a research-only AI-guided workflow for identifying cancer-associated targets, prioritizing possible mRNA vaccine candidates, and using CRISPR-based concepts for antigen-validation research. This is an early-stage computational and experimental concept, not a clinical treatment or approved vaccine.

Provisional Filing

Lateral Flow Immunoassay Apparatus for Rapid Detection and Quantification of Allergen-Specific IgE Antibodies

Application No.63/931,575
Receipt DateDecember 5, 2025
InventorRami Mohaned Mahdi Alkhaleeli

This provisional filing focuses on a rapid lateral-flow immunoassay concept for detecting and estimating allergen-specific IgE antibodies. The goal is to support fast, accessible allergy-related screening research using a portable test-format concept.

Provisional Filing

Artificial Intelligence Designed Synthetic Binding Protein Colorimetric Biosensor Platform for Rapid Diagnostic Detection and Classification of Gram Negative Bacteria, Gram Positive Bacteria, and Fungal Pathogens

Application No.64/004,904
Receipt DateMarch 13, 2026
InventorRami M. Alkhaleeli

This provisional filing describes an AI-designed biosensor platform using synthetic binding proteins and colorimetric detection concepts to identify and classify bacterial and fungal pathogens. The concept is intended for research and prototype development, not clinical diagnostic use unless validated and cleared by regulators.

Provisional Filing

The Five-Stage Magneto-Mechanical RF Harvester for Battery-Free Phones

Application No.64/017,342
Receipt DateMarch 26, 2026
InventorMr. Rami M. Alkhaleeli

This provisional filing presents an energy-harvesting concept combining magneto-mechanical motion and RF-related energy-capture ideas for battery-free or emergency power applications. It represents early-stage engineering research into alternative micro-power generation.

USPTO Receipts & Patent Records

Important Disclaimer: Some records shown are provisional patent applications and are not issued patents. Provisional applications are early-stage USPTO filings and do not by themselves represent granted patent rights. Medical, scientific, diagnostic, and therapeutic concepts shown here are research-only and are not FDA-cleared, clinically validated, or intended for diagnosis, treatment, cure, or clinical decision-making unless specifically approved through the appropriate regulatory process.

Alkhaleeli BioAI LLC presents this portfolio for informational, educational, and research-innovation purposes. All medical and biotechnology concepts require laboratory validation, safety testing, regulatory review, and appropriate approvals before any clinical or commercial use.